Financhill
Back

Akero Therapeutics Quote, Financials, Valuation and Earnings

America's Final Republican President

Click here to see his 2024 election prediction.
Sell
34

AKRO
Akero Therapeutics

Last Price:
20.53
Seasonality Move:
19.37%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Akero Therapeutics Price Quote

$20.53
-1.07 (-4.95%)
(Updated: April 18, 2024 at 6:55 PM ET)

Akero Therapeutics Key Stats

Sell
34
Akero Therapeutics (AKRO) is a Sell

Day range:
$21.57 - $22.18
52-week range:
$11.25 - $58.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.78%

Volume:
818.3K
Avg. volume:
1.4M
1-year change:
-46.35%
Market cap:
$1.5B
Revenue:
$0
EPS:
$-2.88

How Much Does Akero Therapeutics Make?

Data Unavailable

Is Akero Therapeutics Growing As A Company?

Data Unavailable

Akero Therapeutics Stock Price Performance

What Is Akero Therapeutics 52-Week High & Low?

Akero Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akero Therapeutics?

Is Akero Therapeutics Cash Flow Positive?

  • What Is AKRO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$145.4M
  • What Is Akero Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $353.3M
  • What Is Akero Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$223.6M

Akero Therapeutics Return On Invested Capital

Data Unavailable

Akero Therapeutics Earnings Date & Stock Price

Akero Therapeutics Competitors

  • Who Are Akero Therapeutics's Competitors?
    Below is a list of companies who compete with Akero Therapeutics or are related in some way:
    • 89bio Inc (ETNB)
    • Ionis Pharmaceuticals Inc (IONS)
    • Eli Lilly and Co (LLY)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • Viking Therapeutics Inc (VKTX)

Akero Therapeutics Dividend Yield

Data Unavailable

Akero Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -19.56%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 50.00
Upside from Last Price: 131.48%

Major Shareholders

  • How many AKRO shares are owned by institutional investors?
    89.2M AKRO shares are owned by institutional investors
  • How many AKRO shares are owned by insiders?
    1.3M AKRO shares are owned by insiders